Bronchopulmonary dysplasia: Pathophysiology and potential anti-inflammatory therapies

Paris C. Papagianis, J. J. Pillow, Timothy J. Moss

Research output: Contribution to journalReview ArticleResearchpeer-review

7 Citations (Scopus)


Inflammation of the preterm lungs is key to the pathogenesis of bronchopulmonary dysplasia (BPD), whether it arises as a consequence of intrauterine inflammation or postnatal respiratory management. This review explores steroidal and non-steroidal therapies for reducing neonatal pulmonary inflammation, aimed at treating or preventing BPD.

Original languageEnglish
Pages (from-to)34-41
Number of pages8
JournalPaediatric Respiratory Reviews
Publication statusPublished - 1 Apr 2019


  • Bronchopulmonary dysplasia
  • Chorioamnionitis
  • Dexamethasone
  • Glucocorticoid
  • Inflammation
  • Pulmonary

Cite this